AMCP webinar that reviewed the major provisions contained in a recently released advanced notice of proposed rulemaking from CMS on the International Drug Pricing Index for Part B drugs and a recently proposed rule on the Medicare Advantage and Part D Program.
AMCP webinar that reviewed the major provisions contained in a recently released advanced notice of proposed rulemaking from CMS on the International Drug Pricing Index for Part B drugs and a recently proposed rule on the Medicare Advantage and Part D Program.
AMCP webinar that reviewed the major provisions contained in a recently released advanced notice of proposed rulemaking from CMS on the International Drug Pricing Index for Part B drugs and a recently proposed rule on the Medicare Advantage and Part D Program.
AMCP webinar that reviewed AMCP’s activity related to preapproval information exchange (PIE) and provided the payer and manufacturer perspective on the important and usefulness of PIE.
AMCP webinar that reviewed AMCP’s activity related to preapproval information exchange (PIE) and provided the payer and manufacturer perspective on the important and usefulness of PIE.
AMCP comments on legislation that would increase competition and decrease patients' drug costs.
AMCP participants in sign-on letter from 60 organizations in support of increasing FDA funding for FY 2019.
